Lastly, while our data establish MSC-Exos as an effective corrector of Tfh/Tfr imbalance in SLE, this mechanism may extend to other inflammatory conditions where Tfh/Tfr dysregulation serves as an indicator of autoimmune pathology severity. The gene discussed is TFRC; the disease is systemic lupus erythematosus.